[Development and application of gene therapy technologies].
Ozawa
Keiya
K
Division of Hematology, Department of Medicine, Jichi Medical School, 3311- 1 Yakushiji, Minamikawachi-machi Kawachi-gun, Tochigi 329-0498, Japan. kozawa@ms2.jichi.ac.jp
D048868:Adaptor Proteins, Signal Transducing; D000818:Animals; D004268:DNA-Binding Proteins / Q000235:genetics; D000229:Dependovirus / Q000235:genetics; D005786:Gene Expression Regulation; D018014:Gene Transfer Techniques / Q000009:adverse effects; D015316:Genetic Therapy / Q000009:adverse effects / Q000379:methods* / Q000639:trends; D005822:Genetic Vectors / Q000009:adverse effects; D006412:Hematopoietic Stem Cells; D006801:Humans; D060588:LIM Domain Proteins; D007938:Leukemia / Q000209:etiology; D008667:Metalloproteins / Q000235:genetics; D016254:Mutagenesis, Insertional; D010300:Parkinson Disease / Q000628:therapy; D011518:Proto-Oncogene Proteins; D012190:Retroviridae; D016511:Severe Combined Immunodeficiency / Q000628:therapy; D019076:Transgenes
D048868:Adaptor Proteins, Signal Transducing; D004268:DNA-Binding Proteins; D060588:LIM Domain Proteins; C085117:LMO2 protein, human; D008667:Metalloproteins; D011518:Proto-Oncogene Proteins